These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3940213)

  • 41. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S; Yano O; Tokunaga T
    Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.
    Wiltrout RH; Boyd MR; Back TC; Salup RR; Arthur JA; Hornung RL
    J Immunol; 1988 May; 140(9):3261-5. PubMed ID: 3258894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model.
    Varkila K; Hurme M
    Immunology; 1985 Jan; 54(1):121-6. PubMed ID: 3972429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of tumor immunity and natural killer cell cytotoxicity in mice by 5-halo-6-phenyl pyrimidinone.
    Lotzová E; Savary CA; Pollack S; Hanna N
    Cancer Res; 1986 Oct; 46(10):5004-8. PubMed ID: 3756861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
    Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
    Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro enhancement of bone marrow natural killer cells after incubation with thymopoietin32-36 (TP-5).
    Fiorilli M; Sirianni MC; Sorrentino V; Testi R; Aiuti F
    Thymus; 1983 Sep; 5(5-6):375-82. PubMed ID: 6197787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
    Riser BL; Laybourn KA; Varani J
    Nat Immun Cell Growth Regul; 1988; 7(5-6):305-15. PubMed ID: 3221908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
    Suzuki F; Brutkiewicz RR; Pollard RB
    J Natl Cancer Inst; 1986 Aug; 77(2):441-7. PubMed ID: 3090339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction.
    Mowat AM; Felstein MV
    Immunology; 1987 Jun; 61(2):179-83. PubMed ID: 3596637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
    Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.